Sökning: L773:2197 425X > Fluid restrictive r...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04830naa a2200481 4500 | |
001 | oai:DiVA.org:uu-494128 | |
003 | SwePub | |
008 | 230115s2023 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4941282 URI |
024 | 7 | a https://doi.org/10.1186/s40635-023-00548-w2 DOI |
040 | a (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Barrueta Tenhunen, Annelieu Uppsala universitet,Anestesiologi och intensivvård4 aut0 (Swepub:uu)annba203 |
245 | 1 0 | a Fluid restrictive resuscitation with high molecular weight hyaluronan infusion in early peritonitis sepsis |
264 | 1 | b Springer Nature,c 2023 |
338 | a electronic2 rdacarrier | |
500 | a Title in the list of papers of Annelie Barrueta Tenhunen's thesis: Fluid restrictive resuscitation with high molecular weight hyaluronan infusion in early peritonitis-sepsis | |
520 | a Sepsis is a condition with high morbidity and mortality. Prompt recognition and initiation of treatment is essential. Despite forming an integral part of sepsis management, fluid resuscitation may also lead to volume overload, which in turn is associated with increased mortality. The optimal fluid strategy in sepsis resuscitation is yet to be defined. Hyaluronan, an endogenous glycosaminoglycan with high affinity to water is an important constituent of the endothelial glycocalyx. We hypothesized that exogenously administered hyaluronan would counteract intravascular volume depletion and contribute to endothelial glycocalyx integrity in a fluid restrictive model of peritonitis. In a prospective, blinded model of porcine peritonitis sepsis, we randomized animals to intervention with hyaluronan (n = 8) or 0.9% saline (n = 8). The animals received an infusion of 0.1% hyaluronan 6 ml/kg/h, or the same volume of saline, during the first 2 h of peritonitis. Stroke volume variation and hemoconcentration were comparable in the two groups throughout the experiment. Cardiac output was higher in the intervention group during the infusion of hyaluronan (3.2 ± 0.5 l/min in intervention group vs 2.7 ± 0.2 l/min in the control group) (p = 0.039). The increase in lactate was more pronounced in the intervention group (3.2 ± 1.0 mmol/l in the intervention group and 1.7 ± 0.7 mmol/l in the control group) at the end of the experiment (p < 0.001). Concentrations of surrogate markers of glycocalyx damage; syndecan 1 (0.6 ± 0.2 ng/ml vs 0.5 ± 0.2 ng/ml, p = 0.292), heparan sulphate (1.23 ± 0.2 vs 1.4 ± 0.3 ng/ml, p = 0.211) and vascular adhesion protein 1 (7.0 ± 4.1 vs 8.2 ± 2.3 ng/ml, p = 0.492) were comparable in the two groups at the end of the experiment. In conclusion, hyaluronan did not counteract intravascular volume depletion in early peritonitis sepsis. However, this finding is hampered by the short observation period and a beneficial effect of HMW-HA in peritonitis sepsis cannot be discarded based on the results of the present study. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Anestesi och intensivvård0 (SwePub)302012 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Anesthesiology and Intensive Care0 (SwePub)302012 hsv//eng |
653 | a animal model | |
653 | a inflammation | |
653 | a glycocalyx | |
653 | a fluid therapy | |
653 | a colloid | |
653 | a Anestesiologi och intensivvård | |
653 | a Anaesthesiology and Intensive Care | |
700 | 1 | a van der Heijden, Jaapu Uppsala universitet,Anestesiologi och intensivvård4 aut0 (Swepub:uu)jaaho800 |
700 | 1 | a Skorup, Paulu Uppsala universitet,Infektionsmedicin4 aut0 (Swepub:uu)pausk660 |
700 | 1 | a Maccarana, Marcou Uppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi4 aut0 (Swepub:uu)marma713 |
700 | 1 | a Larsson, Andersu Uppsala universitet,Klinisk kemi4 aut0 (Swepub:uu)andlarss |
700 | 1 | a Larsson, Andersu Uppsala universitet,Hedenstiernalaboratoriet4 aut0 (Swepub:uu)andla606 |
700 | 1 | a Perchiazzi, Gaetanou Uppsala universitet,Hedenstiernalaboratoriet4 aut0 (Swepub:uu)gpe24447 |
700 | 1 | a Tenhunen, Jyrkiu Uppsala universitet,Anestesiologi och intensivvård4 aut0 (Swepub:uu)jyrte348 |
710 | 2 | a Uppsala universitetb Anestesiologi och intensivvård4 org |
773 | 0 | t Intensive Care Medicine Experimentald : Springer Natureg 11:1q 11:1x 2197-425X |
856 | 4 | u https://doi.org/10.1186/s40635-023-00548-wy Fulltext |
856 | 4 | u https://uu.diva-portal.org/smash/get/diva2:1727102/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-494128 |
856 | 4 8 | u https://doi.org/10.1186/s40635-023-00548-w |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.